Rédai, E.M.; Sipos, E.; Vlad, R.A.; Antonoaea, P.; Todoran, N.; Ciurba, A.
Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations. Processes 2022, 10, 2722.
https://doi.org/10.3390/pr10122722
AMA Style
Rédai EM, Sipos E, Vlad RA, Antonoaea P, Todoran N, Ciurba A.
Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations. Processes. 2022; 10(12):2722.
https://doi.org/10.3390/pr10122722
Chicago/Turabian Style
Rédai, Emőke Margit, Emese Sipos, Robert Alexandru Vlad, Paula Antonoaea, Nicoleta Todoran, and Adriana Ciurba.
2022. "Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations" Processes 10, no. 12: 2722.
https://doi.org/10.3390/pr10122722
APA Style
Rédai, E. M., Sipos, E., Vlad, R. A., Antonoaea, P., Todoran, N., & Ciurba, A.
(2022). Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations. Processes, 10(12), 2722.
https://doi.org/10.3390/pr10122722